Metrics

Published Proposals

Access to clinical trial data provides opportunities to conduct further research that can help advance medical science or improve patient care. This helps ensure the data provided by research participants are used to maximum effect in the creation of knowledge and understanding.

Proposal number	Sponsor/Funder	Title	Lead researcher
631	GSK	Predictors of BPH Progression	Dr. Stephen Freedland, MD	Further Details
647	GSK	Assessing and Reporting Heterogeneity of Treatment Effect in Randomized Clinical Trials	David M. Kent, MD, MSc	Further Details
651	GSK	Descriptive evaluation of SAE reporting rates in vaccine clinical trials among Latin American children.	Thomas Verstraeten	Further Details
669	GSK	A multi-center, double-blind, placebo controlled study of paroxetine and imipramine in adolescents with unipolar major depression - efficacy and adverse outcomes.	Jon Jureidini	Further Details
674	GSK	Antiepileptic drug monotherapy for epilepsy: an overview of systematic reviews and network meta-analysis	Antony Marson	Further Details
911	GSK	Outcome Measures in Systemic Lupus Erythematosus: Constructing a Meaningful Response Index from Existing Clinical Trial Data	Lindsy Forbess, MD, MSc	Further Details
930	GSK	MASTERMIND: Stratification of glycaemic response the ADOPT and RECORD studies	Professor Andrew Hattersley, M.D. FRS	Further Details
945	ViiV	THE CD4/CD8 RATIO AS A PREDICTOR OF NON-AIDS EVENTS DURING ANTIRRETROVIRAL THERAPY: CONFIRMATION OF ITS PREDICTIVE VALUE AND IMPACT OF MARAVIROC IN TREATMENT-EXPERIENCED PATIENTS	Santiago Moreno	Further Details
946	GSK, Roche	Assessing models for changes in tumour size over time and how they relate to survival times.	Raluca Eftimie	Further Details
977	GSK	The implication of central adjudication of COPD exacerbations by experts for treatment effect estimates and sample size calculation	Milo Puhan	Further Details

First 1 2 3 4 Last